{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T02:52:27Z","timestamp":1786935147998,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100015411","name":"Ara Parseghian Medical Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["ZIA HD008989"],"award-info":[{"award-number":["ZIA HD008989"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001790","name":"Ara Parseghian Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.gim.2022.11.017","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T01:28:41Z","timestamp":1670203721000},"page":"100349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Neurofilament light chain in cerebrospinal fluid as a novel biomarker in evaluating both clinical severity and therapeutic response in Niemann-Pick disease type C1"],"prefix":"10.1016","volume":"25","author":[{"given":"Neena","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Y.","family":"Farhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninet","family":"Sinaii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An Dang","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changrui","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Berry-Kravis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Bianconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruturaj","family":"Masvekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibiana","family":"Bielekova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9397-0046","authenticated-orcid":false,"given":"Forbes D.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gim.2022.11.017_bib1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-5-16","article-title":"Niemann-Pick disease type C","volume":"5","author":"Vanier","year":"2010","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"10.1016\/j.gim.2022.11.017_bib2","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jnc.14895","article-title":"Niemann-Pick type C disease: cellular pathology and pharmacotherapy","volume":"153","author":"Wheeler","year":"2020","journal-title":"J\u00a0Neurochem"},{"issue":"1","key":"10.1016\/j.gim.2022.11.017_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13023-018-0913-4","article-title":"Adult Niemann-Pick disease type C in France: clinical phenotypes and long-term miglustat treatment effect","volume":"13","author":"Nadjar","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.gim.2022.11.017_bib4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ajmg.b.30969","article-title":"Linear clinical progression, independent of age of onset, in Niemann-Pick disease, type C","volume":"153B","author":"Yanjanin","year":"2010","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1","key":"10.1016\/j.gim.2022.11.017_bib5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1186\/s13023-021-02115-6","article-title":"International consensus on clinical severity scale use in evaluating Niemann-Pick disease type C in paediatric and adult patients: results from a Delphi study","volume":"16","author":"Evans","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.gim.2022.11.017_bib6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13023-018-0880-9","article-title":"Annual severity increment score as a tool for stratifying patients with Niemann-Pick disease type C and for recruitment to clinical trials","volume":"13","author":"Cortina-Borja","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.gim.2022.11.017_bib7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40265-013-0164-6","article-title":"Miglustat: a review of its use in Niemann-Pick disease type C","volume":"74","author":"Lyseng-Williamson","year":"2014","journal-title":"Drugs"},{"issue":"10104","key":"10.1016\/j.gim.2022.11.017_bib8","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0140-6736(17)31465-4","article-title":"Intrathecal 2-hydroxypropyl-\u03b2-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial","volume":"390","author":"Ory","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.gim.2022.11.017_bib9","article-title":"A\u00a0phase 1\/2 open label nonrandomized clinical trial of intravenous 2-hydroxypropyl-\u03b2-cyclodextrin for acute liver disease in infants with Niemann-Pick C1","volume":"28","author":"Reynolds","year":"2021","journal-title":"Mol Genet Metab Rep"},{"issue":"10","key":"10.1016\/j.gim.2022.11.017_bib10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"10.1016\/j.gim.2022.11.017_bib11","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018309","article-title":"Neurofilaments and neurofilament proteins in health and disease","volume":"9","author":"Yuan","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"9","key":"10.1016\/j.gim.2022.11.017_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075091","article-title":"Increased neurofilament light chain blood levels in neurodegenerative neurological diseases","volume":"8","author":"Gaiottino","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.gim.2022.11.017_bib13","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1136\/jnnp.64.3.402","article-title":"Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis","volume":"64","author":"Lycke","year":"1998","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.gim.2022.11.017_bib14","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1212\/WNL.52.5.1090","article-title":"Neurofilament protein levels in CSF are increased in dementia","volume":"52","author":"Rosengren","year":"1999","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.gim.2022.11.017_bib15","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1212\/01.wnl.0000203120.85850.54","article-title":"Axonal damage markers in cerebrospinal fluid are increased in ALS","volume":"66","author":"Brettschneider","year":"2006","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.gim.2022.11.017_bib16","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1046\/j.1471-4159.1996.67052013.x","article-title":"Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF","volume":"67","author":"Rosengren","year":"1996","journal-title":"J\u00a0Neurochem"},{"issue":"8","key":"10.1016\/j.gim.2022.11.017_bib17","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1474-4422(17)30124-2","article-title":"Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington\u2019s disease: a retrospective cohort analysis","volume":"16","author":"Byrne","year":"2017","journal-title":"Lancet Neurol"},{"issue":"19","key":"10.1016\/j.gim.2022.11.017_bib18","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1212\/WNL.0000000000003912","article-title":"Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports","volume":"88","author":"Shahim","year":"2017","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.gim.2022.11.017_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ana.22247","article-title":"Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab","volume":"69","author":"Gunnarsson","year":"2011","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.gim.2022.11.017_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuron.2016.05.018","article-title":"Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases","volume":"91","author":"Bacioglu","year":"2016","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.gim.2022.11.017_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/jnnp.2009.177667","article-title":"Neurofilament light chain levels in ventricular cerebrospinal fluid after acute aneurysmal subarachnoid haemorrhage","volume":"82","author":"Zanier","year":"2011","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"1-2","key":"10.1016\/j.gim.2022.11.017_bib22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neulet.2006.05.029","article-title":"CSF-neurofilament correlates with outcome after aneurysmal subarachnoid hemorrhage","volume":"404","author":"Nyl\u00e9n","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.gim.2022.11.017_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/srep36791","article-title":"Serum neurofilament light protein predicts clinical outcome in traumatic brain injury","volume":"6","author":"Shahim","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.gim.2022.11.017_bib24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00417897","article-title":"A\u00a0penetration-aspiration scale","volume":"11","author":"Rosenbek","year":"1996","journal-title":"Dysphagia"},{"issue":"4","key":"10.1016\/j.gim.2022.11.017_bib26","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/ana.26446","article-title":"Contributors to serum NfL levels in people without neurologic disease","volume":"92","author":"Fitzgerald","year":"2022","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.gim.2022.11.017_bib27","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/s41467-020-14612-6","article-title":"Serum neurofilament light levels in normal aging and their association with morphologic brain changes","volume":"11","author":"Khalil","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.gim.2022.11.017_bib28","doi-asserted-by":"crossref","first-page":"fcac174","DOI":"10.1093\/braincomms\/fcac174","article-title":"Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5-90 years","volume":"4","author":"Simr\u00e9n","year":"2022","journal-title":"Brain Commun"},{"issue":"20","key":"10.1016\/j.gim.2022.11.017_bib29","first-page":"4796","article-title":"Plasma neurofilament light (NfL) in patients affected by Niemann-Pick type C disease (NPCD)","volume":"10","author":"Dardis","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"6","key":"10.1016\/j.gim.2022.11.017_bib30","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1177\/0004867419893431","article-title":"Cerebrospinal fluid neurofilament light chain is elevated in Niemann-Pick type C compared to psychiatric disorders and healthy controls and may be a marker of treatment response","volume":"54","author":"Eratne","year":"2020","journal-title":"Aust N Z J Psychiatry"},{"issue":"1-3","key":"10.1016\/j.gim.2022.11.017_bib31","first-page":"11","article-title":"Longitudinal data in patients with Niemann-Pick type C disease under combined high intrathecal and low intravenous dose of 2-hydroxylpropyl-beta-cyclodextrin","volume":"18","author":"Bountouvi","year":"2021","journal-title":"Innov Clin Neurosci"},{"issue":"1","key":"10.1016\/j.gim.2022.11.017_bib32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13023-021-01719-2","article-title":"Validation of the 5-domain Niemann-Pick type C Clinical Severity Scale","volume":"16","author":"Patterson","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"1-2","key":"10.1016\/j.gim.2022.11.017_bib33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jns.2012.07.043","article-title":"Serum neurofilament concentrations in children with prolonged febrile seizures","volume":"321","author":"Matsushige","year":"2012","journal-title":"J\u00a0Neurol Sci"},{"issue":"1","key":"10.1016\/j.gim.2022.11.017_bib34","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1111\/epi.17132","article-title":"Serum neurofilament light as biomarker of seizure-related neuronal injury in status epilepticus","volume":"63","author":"Giovannini","year":"2022","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.gim.2022.11.017_bib35","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1001\/jamaneurol.2020.3241","article-title":"Association of miglustat with swallowing outcomes in Niemann-Pick disease, type C1","volume":"77","author":"Solomon","year":"2020","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.gim.2022.11.017_bib36","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/jimd.12245","article-title":"Long-term survival outcomes of patients with Niemann-Pick disease type C receiving miglustat treatment: a large retrospective observational study","volume":"43","author":"Patterson","year":"2020","journal-title":"J\u00a0Inherit Metab Dis"}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360022010371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360022010371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:55:18Z","timestamp":1761098118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360022010371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1098360022010371"],"URL":"https:\/\/doi.org\/10.1016\/j.gim.2022.11.017","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurofilament light chain in cerebrospinal fluid as a novel biomarker in evaluating both clinical severity and therapeutic response in Niemann-Pick disease type C1","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gim.2022.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics.","name":"copyright","label":"Copyright"}],"article-number":"100349"}}